I27.23
Pulmonary hypertension due to lung diseases and hypoxia
Clinical Classification Guidelines
Inclusion Terms
- Group 3 pulmonary hypertension
Code Also
- associated lung disease, if known, such as:
- bronchiectasis (J47.-)
- cystic fibrosis with pulmonary manifestations (E84.0)
- interstitial lung disease (J84.-)
- pleural effusion (J90)
- sleep apnea (G47.3-)
Medical Intelligence & Overview
Pulmonary hypertension due to lung diseases and hypoxia, classified under ICD-10 code I27.23, is a specific form of high blood pressure that affects the arteries in the lungs and the right side of the heart. This condition belongs to Group 3 pulmonary hypertension, which results from lung-related illnesses or chronic hypoxia. It can significantly impact breathing and heart function, requiring awareness and management to improve quality of life.
Causes & Symptoms
Clinical Causes: Chronic lung diseases such as chronic obstructive pulmonary disease (COPD), interstitial lung disease, or cystic fibrosis Long-term hypoxia due to living at high altitudes or severe sleep apnea Other lung conditions and restrictions that impair oxygen transfer Persistent lung infections that lead to scarring and reduced lung capacity
Key Symptoms: Shortness of breath, especially during physical activity Fatigue and general low energy Chest discomfort or pain Dizziness or fainting spells Swelling in the ankles, legs, or abdomen due to fluid buildup Rapid heartbeat or pounding in the chest
Diagnostic & Treatment
Diagnosis Path: Diagnosing pulmonary hypertension due to lung diseases involves a combination of medical history, physical examination, and specialized tests: - Chest X-ray and high-resolution computed tomography (CT) scan to assess lung structure - Echocardiogram to evaluate heart function and estimate pulmonary artery pressure - Pulmonary function tests to measure lung capacity and airflow - Blood tests to check oxygen and carbon dioxide levels - Right heart catheterization, a definitive test measuring blood pressure in pulmonary arteries - Oxygen saturation assessments to detect hypoxia These evaluations aim to confirm the presence of pulmonary hypertension related to lung disease and determine its severity.
Treatment Protocols: Management of pulmonary hypertension due to lung diseases emphasizes addressing the primary lung condition and improving oxygenation: - Supplemental oxygen therapy to relieve hypoxia - Treatment of underlying lung diseases, including medications, pulmonary rehabilitation, and lifestyle changes - Medications that relax and open pulmonary blood vessels, such as phosphodiesterase inhibitors - Diuretics to reduce fluid accumulation and relieve swelling - Physical activity modifications and pulmonary rehabilitation programs - Regular monitoring and follow-up with healthcare providers In some cases, advanced interventions or transplantation might be considered if the disease progresses significantly.
Clinical Advice & FAQs
Billing Guidance
Is I27.23 a billable ICD-10 code?
Yes, I27.23 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report I27.23?
Clinical documentation must specify the nature of Pulmonary hypertension due to lung diseases and hypoxia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference